1 |
Pawlak, M., Ho, A.W., and Kuchroo, V.K. (2020). Cytokines and transcription factors in the differentiation of CD4(+) T helper cell subsets and induction of tissue inflammation and autoimmunity. Curr. Opin. Immunol. 67, 57-67.
DOI
|
2 |
Roberts, C.A., Dickinson, A.K., and Taams, L.S. (2015). The interplay between monocytes/macrophages and CD4(+) T cell subsets in rheumatoid arthritis. Front. Immunol. 6, 571.
|
3 |
Ruterbusch, M., Pruner, K.B., Shehata, L., and Pepper, M. (2020). In vivo CD4(+) T cell differentiation and function: revisiting the Th1/Th2 paradigm. Annu. Rev. Immunol. 38, 705-725.
DOI
|
4 |
d'Hennezel, E., Bin Dhuban, K., Torgerson, T., and Piccirillo, C.A. (2012). The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 49, 291-302.
DOI
|
5 |
Donald, J.E., Kulp, D.W., and DeGrado, W.F. (2011). Salt bridges: geometrically specific, designable interactions. Proteins 79, 898-915.
DOI
|
6 |
Duan, G. and Walther, D. (2015). The roles of post-translational modifications in the context of protein interaction networks. PLoS Comput. Biol. 11, e1004049.
DOI
|
7 |
Glozak, M.A., Sengupta, N., Zhang, X., and Seto, E. (2005). Acetylation and deacetylation of non-histone proteins. Gene 363, 15-23.
DOI
|
8 |
Guccione, E. and Richard, S. (2019). The regulation, functions and clinical relevance of arginine methylation. Nat. Rev. Mol. Cell Biol. 20, 642-657.
DOI
|
9 |
Han, L., Yang, J., Wang, X., Wu, Q., Yin, S., Li, Z., Zhang, J., Xing, Y., Chen, Z., Tsun, A., et al. (2014). The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor gammat (RORgammat) in Th17 cells. J. Biol. Chem. 289, 25546-25555.
DOI
|
10 |
Hsu, C.Y., Yeh, L.T., Fu, S.H., Chien, M.W., Liu, Y.W., Miaw, S.C., Chang, D.M., and Sytwu, H.K. (2018). SUMO-defective c-Maf preferentially transactivates Il21 to exacerbate autoimmune diabetes. J. Clin. Invest. 128, 3779-3793.
DOI
|
11 |
Hwang, E.S., Hong, J.H., and Glimcher, L.H. (2005a). IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508. J. Exp. Med. 202, 1289-1300.
DOI
|
12 |
Hwang, J.R., Byeon, Y., Kim, D., and Park, S.G. (2020). Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development. Exp. Mol. Med. 52, 750-761.
DOI
|
13 |
Imbratta, C., Hussein, H., Andris, F., and Verdeil, G. (2020). c-MAF, a Swiss army knife for tolerance in lymphocytes. Front. Immunol. 11, 206.
DOI
|
14 |
Snyder, K.J., Zitzer, N.C., Gao, Y., Choe, H.K., Sell, N.E., Neidemire-Colley, L., Ignaci, A., Kale, C., Devine, R.D., Abad, M.G., et al. (2020). PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease. JCI Insight 5, e131099.
DOI
|
15 |
Hsu, C.Y., Fu, S.H., Chien, M.W., Liu, Y.W., Chen, S.J., and Sytwu, H.K. (2020). Post-translational modifications of transcription factors harnessing the etiology and pathophysiology in colonic diseases. Int. J. Mol. Sci. 21, 3207.
DOI
|
16 |
Rutz, S. and Ouyang, W. (2016). The Itch to degrade ROR-gammat. Nat. Immunol. 17, 898-900.
DOI
|
17 |
Shevyrev, D. and Tereshchenko, V. (2019). Treg heterogeneity, function, and homeostasis. Front. Immunol. 10, 3100.
DOI
|
18 |
Curran, A.M., Naik, P., Giles, J.T., and Darrah, E. (2020). PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets. Nat. Rev. Rheumatol. 16, 301-315.
DOI
|
19 |
de Jesus, T.J., Tomalka, J.A., Centore, J.T., Staback Rodriguez, F.D., Agarwal, R.A., Liu, A.R., Kern, T.S., and Ramakrishnan, P. (2021). Negative regulation of FOXP3 expression by c-Rel O-GlcNAcylation. Glycobiology 2021 Jan 12 [Epub]. https://doi.org/10.1093/glycob/cwab001
DOI
|
20 |
Singh, A.K., Khare, P., Obaid, A., Conlon, K.P., Basrur, V., DePinho, R.A., and Venuprasad, K. (2018). SUMOylation of ROR-gammat inhibits IL-17 expression and inflammation via HDAC2. Nat. Commun. 9, 4515.
DOI
|
21 |
Song, N., Cao, C., Tang, Y., Bi, L., Jiang, Y., Zhou, Y., Song, X., Liu, L., and Ge, W. (2018). The ubiquitin ligase SCF(FBXW7alpha) promotes GATA3 degradation. J. Cell. Physiol. 233, 2366-2377.
DOI
|
22 |
Asano, M., Toda, M., Sakaguchi, N., and Sakaguchi, S. (1996). Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387-396.
DOI
|
23 |
Rutz, S., Kayagaki, N., Phung, Q.T., Eidenschenk, C., Noubade, R., Wang, X., Lesch, J., Lu, R., Newton, K., Huang, O.W., et al. (2015). Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature 518, 417-421.
DOI
|
24 |
Barber, K.W. and Rinehart, J. (2018). The ABCs of PTMs. Nat. Chem. Biol. 14, 188-192.
DOI
|
25 |
Beier, U.H., Akimova, T., Liu, Y., Wang, L., and Hancock, W.W. (2011). Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells. Curr. Opin. Immunol. 23, 670-678.
DOI
|
26 |
Yang, Y., He, Y., Wang, X., Liang, Z., He, G., Zhang, P., Zhu, H., Xu, N., and Liang, S. (2017). Protein SUMOylation modification and its associations with disease. Open Biol. 7, 170167.
DOI
|
27 |
Young, R.L., Page, A.J., Cooper, N.J., Frisby, C.L., and Blackshaw, L.A. (2010). Sensory and motor innervation of the crural diaphragm by the vagus nerves. Gastroenterology 138, 1091-1101.e5.
DOI
|
28 |
Lin, B.S., Tsai, P.Y., Hsieh, W.Y., Tsao, H.W., Liu, M.W., Grenningloh, R., Wang, L.F., Ho, I.C., and Miaw, S.C. (2010). SUMOylation attenuates c-Mafdependent IL-4 expression. Eur. J. Immunol. 40, 1174-1184.
DOI
|
29 |
Li, Z., Lin, F., Zhuo, C., Deng, G., Chen, Z., Yin, S., Gao, Z., Piccioni, M., Tsun, A., Cai, S., et al. (2014). PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation. J. Biol. Chem. 289, 26872-26881.
DOI
|
30 |
Lim, H.W., Kang, S.G., Ryu, J.K., Schilling, B., Fei, M., Lee, I.S., Kehasse, A., Shirakawa, K., Yokoyama, M., Schnolzer, M., et al. (2015). SIRT1 deacetylates RORgammat and enhances Th17 cell generation. J. Exp. Med. 212, 973.
DOI
|
31 |
Liu, B., Salgado, O.C., Singh, S., Hippen, K.L., Maynard, J.C., Burlingame, A.L., Ball, L.E., Blazar, B.R., Farrar, M.A., Hogquist, K.A., et al. (2019). The lineage stability and suppressive program of regulatory T cells require protein O-GlcNAcylation. Nat. Commun. 10, 354.
DOI
|
32 |
Kitagawa, K., Shibata, K., Matsumoto, A., Matsumoto, M., Ohhata, T., Nakayama, K.I., Niida, H., and Kitagawa, M. (2014). Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development. Mol. Cell. Biol. 34, 2732-2744.
DOI
|
33 |
Ivanov, I.I., McKenzie, B.S., Zhou, L., Tadokoro, C.E., Lepelley, A., Lafaille, J.J., Cua, D.J., and Littman, D.R. (2006). The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133.
DOI
|
34 |
Zhang, Z., Tong, J., Tang, X., Juan, J., Cao, B., Hurren, R., Chen, G., Taylor, P., Xu, X., Shi, C.X., et al. (2016). The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice. Blood 127, 1676-1686.
DOI
|
35 |
Zhao, X., Zheng, B., Huang, Y., Yang, D., Katzman, S., Chang, C., Fowell, D., and Zeng, W.P. (2007). Interaction between GATA-3 and the transcriptional coregulator Pias1 is important for the regulation of Th2 immune responses. J. Immunol. 179, 8297-8304.
DOI
|
36 |
Yamashita, M., Ukai-Tadenuma, M., Miyamoto, T., Sugaya, K., Hosokawa, H., Hasegawa, A., Kimura, M., Taniguchi, M., DeGregori, J., and Nakayama, T. (2004). Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J. Biol. Chem. 279, 26983-26990.
DOI
|
37 |
Jang, E.J., Park, H.R., Hong, J.H., and Hwang, E.S. (2013). Lysine 313 of T-box is crucial for modulation of protein stability, DNA binding, and threonine phosphorylation of T-bet. J. Immunol. 190, 5764-5770.
DOI
|
38 |
Jenner, R.G., Townsend, M.J., Jackson, I., Sun, K., Bouwman, R.D., Young, R.A., Glimcher, L.H., and Lord, G.M. (2009). The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. Proc. Natl. Acad. Sci. U. S. A. 106, 17876-17881.
DOI
|
39 |
Kagoya, Y., Saijo, H., Matsunaga, Y., Guo, T., Saso, K., Anczurowski, M., Wang, C.H., Sugata, K., Murata, K., Butler, M.O., et al. (2019). Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells. J. Autoimmun. 97, 10-21.
DOI
|
40 |
Kumar, S., Tsai, C.J., and Nussinov, R. (2000). Factors enhancing protein thermostability. Protein Eng. 13, 179-191.
DOI
|
41 |
Kwon, H.S., Lim, H.W., Wu, J., Schnolzer, M., Verdin, E., and Ott, M. (2012). Three novel acetylation sites in the Foxp3 transcription factor regulate the suppressive activity of regulatory T cells. J. Immunol. 188, 2712-2721.
DOI
|
42 |
Lazarevic, V., Chen, X., Shim, J.H., Hwang, E.S., Jang, E., Bolm, A.N., Oukka, M., Kuchroo, V.K., and Glimcher, L.H. (2011). T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat. Nat. Immunol. 12, 96-104.
DOI
|
43 |
Leavenworth, J.W., Ma, X., Mo, Y.Y., and Pauza, M.E. (2009). SUMO conjugation contributes to immune deviation in nonobese diabetic mice by suppressing c-Maf transactivation of IL-4. J. Immunol. 183, 1110-1119.
DOI
|
44 |
Li, B., Samanta, A., Song, X., Iacono, K.T., Bembas, K., Tao, R., Basu, S., Riley, J.L., Hancock, W.W., Shen, Y., et al. (2007). FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl. Acad. Sci. U. S. A. 104, 4571-4576.
DOI
|
45 |
Chemin, K., Gerstner, C., and Malmstrom, V. (2019). Effector functions of CD4+ T cells at the site of local autoimmune inflammation-lessons from rheumatoid arthritis. Front. Immunol. 10, 353.
DOI
|
46 |
Kathania, M., Khare, P., Zeng, M., Cantarel, B., Zhang, H., Ueno, H., and Venuprasad, K. (2016). Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-gammat ubiquitination. Nat. Immunol. 17, 997-1004.
DOI
|
47 |
Bettelli, E., Dastrange, M., and Oukka, M. (2005). Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. U. S. A. 102, 5138-5143.
DOI
|
48 |
Boisvert, F.M., Rhie, A., Richard, S., and Doherty, A.J. (2005). The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity. Cell Cycle 4, 1834-1841.
DOI
|
49 |
Chang, S. and Aune, T.M. (2007). Dynamic changes in histone-methylation 'marks' across the locus encoding interferon-gamma during the differentiation of T helper type 2 cells. Nat. Immunol. 8, 723-731.
DOI
|
50 |
Chang, Y.H., Weng, C.L., and Lin, K.I. (2020). O-GlcNAcylation and its role in the immune system. J. Biomed. Sci. 27, 57.
DOI
|
51 |
Bennett, C.L., Yoshioka, R., Kiyosawa, H., Barker, D.F., Fain, P.R., Shigeoka, A.O., and Chance, P.F. (2000). X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3. Am. J. Hum. Genet. 66, 461-468.
DOI
|
52 |
Pan, F., Yu, H., Dang, E.V., Barbi, J., Pan, X., Grosso, J.F., Jinasena, D., Sharma, S.M., McCadden, E.M., Getnet, D., et al. (2009). Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 325, 1142-1146.
DOI
|
53 |
Fuhrmann, J., Clancy, K.W., and Thompson, P.R. (2015). Chemical biology of protein arginine modifications in epigenetic regulation. Chem. Rev. 115, 5413-5461.
DOI
|
54 |
Marth, J.D. and Grewal, P.K. (2008). Mammalian glycosylation in immunity. Nat. Rev. Immunol. 8, 874-887.
DOI
|
55 |
Martinez-Sanchez, M.E., Huerta, L., Alvarez-Buylla, E.R., and Villarreal Lujan, C. (2018). Role of cytokine combinations on CD4+ T cell differentiation, partial polarization, and plasticity: continuous network modeling approach. Front. Physiol. 9, 877.
DOI
|
56 |
Morawski, P.A., Mehra, P., Chen, C., Bhatti, T., and Wells, A.D. (2013). Foxp3 protein stability is regulated by cyclin-dependent kinase 2. J. Biol. Chem. 288, 24494-24502.
DOI
|
57 |
Nie, H., Zheng, Y., Li, R., Guo, T.B., He, D., Fang, L., Liu, X., Xiao, L., Chen, X., Wan, B., et al. (2013). Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis. Nat. Med. 19, 322-328.
DOI
|
58 |
Ono, M., Yaguchi, H., Ohkura, N., Kitabayashi, I., Nagamura, Y., Nomura, T., Miyachi, Y., Tsukada, T., and Sakaguchi, S. (2007). Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446, 685-689.
DOI
|
59 |
Ostroumov, D., Fekete-Drimusz, N., Saborowski, M., Kuhnel, F., and Woller, N. (2018). CD4 and CD8 T lymphocyte interplay in controlling tumor growth. Cell. Mol. Life Sci. 75, 689-713.
DOI
|
60 |
Liu, Y., Lightfoot, Y.L., Seto, N., Carmona-Rivera, C., Moore, E., Goel, R., O'Neil, L., Mistry, P., Hoffmann, V., Mondal, S., et al. (2018). Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus. JCI Insight 3, e124729.
DOI
|
61 |
Hwang, E.S., Szabo, S.J., Schwartzberg, P.L., and Glimcher, L.H. (2005b). T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307, 430-433.
DOI
|
62 |
Sun, B., Chang, H.H., Salinger, A., Tomita, B., Bawadekar, M., Holmes, C.L., Shelef, M.A., Weerapana, E., Thompson, P.R., and Ho, I.C. (2019). Reciprocal regulation of Th2 and Th17 cells by PAD2-mediated citrullination. JCI Insight 4, e129687.
DOI
|
63 |
Kaplan, M.H., Schindler, U., Smiley, S.T., and Grusby, M.J. (1996). Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4, 313-319.
DOI
|
64 |
Zhu, J. (2017). GATA3 regulates the development and functions of innate lymphoid cell subsets at multiple stages. Front. Immunol. 8, 1571.
DOI
|
65 |
Zhu, J., Jankovic, D., Oler, A.J., Wei, G., Sharma, S., Hu, G., Guo, L., Yagi, R., Yamane, H., Punkosdy, G., et al. (2012). The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity 37, 660-673.
DOI
|
66 |
Zhu, J., Yamane, H., and Paul, W.E. (2010). Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28, 445-489.
DOI
|
67 |
Li, Y., Lu, Y., Wang, S., Han, Z., Zhu, F., Ni, Y., Liang, R., Zhang, Y., Leng, Q., Wei, G., et al. (2016). USP21 prevents the generation of T-helper-1-like Treg cells. Nat. Commun. 7, 13559.
DOI
|
68 |
Celikkaya, H., Cosacak, M.I., Papadimitriou, C., Popova, S., Bhattarai, P., Biswas, S.N., Siddiqui, T., Wistorf, S., Nevado-Alcalde, I., Naumann, L., et al. (2019). GATA3 promotes the neural progenitor state but not neurogenesis in 3D traumatic injury model of primary human cortical astrocytes. Front. Cell. Neurosci. 13, 23.
DOI
|
69 |
DuPage, M. and Bluestone, J.A. (2016). Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease. Nat. Rev. Immunol. 16, 149-163.
DOI
|
70 |
Hosokawa, H., Tanaka, T., Endo, Y., Kato, M., Shinoda, K., Suzuki, A., Motohashi, S., Matsumoto, M., Nakayama, K.I., and Nakayama, T. (2016). Akt1-mediated Gata3 phosphorylation controls the repression of IFNgamma in memory-type Th2 cells. Nat. Commun. 7, 11289.
DOI
|
71 |
Lanouette, S., Mongeon, V., Figeys, D., and Couture, J.F. (2014). The functional diversity of protein lysine methylation. Mol. Syst. Biol. 10, 724.
DOI
|
72 |
Liu, C.C., Lai, C.Y., Yen, W.F., Lin, Y.H., Chang, H.H., Tai, T.S., Lu, Y.J., Tsao, H.W., Ho, I.C., and Miaw, S.C. (2015). Reciprocal regulation of C-Maf tyrosine phosphorylation by Tec and Ptpn22. PLoS One 10, e0127617.
DOI
|
73 |
Pai, S.Y., Truitt, M.L., and Ho, I.C. (2004). GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc. Natl. Acad. Sci. U. S. A. 101, 1993-1998.
DOI
|
74 |
van Loosdregt, J., Vercoulen, Y., Guichelaar, T., Gent, Y.Y., Beekman, J.M., van Beekum, O., Brenkman, A.B., Hijnen, D.J., Mutis, T., Kalkhoven, E., et al. (2010). Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 115, 965-974.
DOI
|
75 |
Yan, F., Mo, X., Liu, J., Ye, S., Zeng, X., and Chen, D. (2017). Thymic function in the regulation of T cells, and molecular mechanisms underlying the modulation of cytokines and stress signaling (Review). Mol. Med. Rep. 16, 7175-7184.
DOI
|
76 |
Ramakrishnan, P., Clark, P.M., Mason, D.E., Peters, E.C., Hsieh-Wilson, L.C., and Baltimore, D. (2013). Activation of the transcriptional function of the NF-kappaB protein c-Rel by O-GlcNAc glycosylation. Sci. Signal. 6, ra75.
DOI
|
77 |
Szabo, S.J., Kim, S.T., Costa, G.L., Zhang, X., Fathman, C.G., and Glimcher, L.H. (2000). A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669.
DOI
|
78 |
Nagai, Y., Ji, M.Q., Zhu, F., Xiao, Y., Tanaka, Y., Kambayashi, T., Fujimoto, S., Goldberg, M.M., Zhang, H., Li, B., et al. (2019). PRMT5 associates with the FOXP3 homomer and when disabled enhances targeted p185(erbB2/neu) tumor immunotherapy. Front. Immunol. 10, 174.
DOI
|
79 |
van Loosdregt, J., Brunen, D., Fleskens, V., Pals, C.E., Lam, E.W., and Coffer, P.J. (2011). Rapid temporal control of Foxp3 protein degradation by sirtuin-1. PLoS One 6, e19047.
DOI
|
80 |
Zaidan, N. and Ottersbach, K. (2018). The multi-faceted role of Gata3 in developmental haematopoiesis. Open Biol. 8, 180152.
DOI
|
81 |
Virag, D., Dalmadi-Kiss, B., Vekey, K., Drahos, L., Klebovich, I., Antal, I., and Ludanyi, K. (2020). Current trends in the analysis of post-translational modifications. Chromatographia 83, 1-10.
DOI
|
82 |
Walsh, G. and Jefferis, R. (2006). Post-translational modifications in the context of therapeutic proteins. Nat. Biotechnol. 24, 1241-1252.
DOI
|
83 |
Wang, A., Zhu, F., Liang, R., Li, D., and Li, B. (2019). Regulation of T cell differentiation and function by ubiquitin-specific proteases. Cell. Immunol. 340, 103922.
DOI
|
84 |
Wang, L., de Zoeten, E.F., Greene, M.I., and Hancock, W.W. (2009). Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells. Nat. Rev. Drug Discov. 8, 969-981.
DOI
|
85 |
van Loosdregt, J., Fleskens, V., Tiemessen, M.M., Mokry, M., van Boxtel, R., Meerding, J., Pals, C.E., Kurek, D., Baert, M.R., Delemarre, E.M., et al. (2013b). Canonical Wnt signaling negatively modulates regulatory T cell function. Immunity 39, 298-310.
DOI
|
86 |
Tanaka, Y., Nagai, Y., Okumura, M., Greene, M.I., and Kambayashi, T. (2020). PRMT5 is required for T cell survival and proliferation by maintaining cytokine signaling. Front. Immunol. 11, 621.
DOI
|
87 |
Tay, C., Kanellakis, P., Hosseini, H., Cao, A., Toh, B.H., Bobik, A., and Kyaw, T. (2019). B cell and CD4 T cell interactions promote development of atherosclerosis. Front. Immunol. 10, 3046.
DOI
|
88 |
van Loosdregt, J., Fleskens, V., Fu, J., Brenkman, A.B., Bekker, C.P., Pals, C.E., Meerding, J., Berkers, C.R., Barbi, J., Grone, A., et al. (2013a). Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity. Immunity 39, 259-271.
DOI
|
89 |
Chen, A., Lee, S.M., Gao, B., Shannon, S., Zhu, Z., and Fang, D. (2011). c-Abl-mediated tyrosine phosphorylation of the T-bet DNA-binding domain regulates CD4+ T-cell differentiation and allergic lung inflammation. Mol. Cell. Biol. 31, 3445-3456.
DOI
|
90 |
Deng, G., Nagai, Y., Xiao, Y., Li, Z., Dai, S., Ohtani, T., Banham, A., Li, B., Wu, S.L., Hancock, W., et al. (2015). Pim-2 kinase influences regulatory T cell function and stability by mediating Foxp3 protein N-terminal phosphorylation. J. Biol. Chem. 290, 20211-20220.
DOI
|
91 |
Swiercz, R., Cheng, D., Kim, D., and Bedford, M.T. (2007). Ribosomal protein rpS2 is hypomethylated in PRMT3-deficient mice. J. Biol. Chem. 282, 16917-16923.
DOI
|
92 |
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A.D., Stroud, J.C., Bates, D.L., Guo, L., Han, A., Ziegler, S.F., et al. (2006). FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375-387.
DOI
|
93 |
Webb, L.M., Amici, S.A., Jablonski, K.A., Savardekar, H., Panfil, A.R., Li, L., Zhou, W., Peine, K., Karkhanis, V., Bachelder, E.M., et al. (2017). PRMT5-selective inhibitors suppress inflammatory t cell responses and experimental autoimmune encephalomyelitis. J. Immunol. 198, 1439-1451.
DOI
|
94 |
Yang, Y. and Bedford, M.T. (2013). Protein arginine methyltransferases and cancer. Nat. Rev. Cancer 13, 37-50.
DOI
|
95 |
Sen, S., He, Z., Ghosh, S., Dery, K.J., Yang, L., Zhang, J., and Sun, Z. (2018). PRMT1 plays a critical role in Th17 differentiation by regulating reciprocal recruitment of STAT3 and STAT5. J. Immunol. 201, 440-450.
DOI
|
96 |
Wang, X., Yang, J., Han, L., Zhao, K., Wu, Q., Bao, L., Li, Z., Lv, L., and Li, B. (2015). TRAF5-mediated Lys-63-linked polyubiquitination plays an essential role in positive regulation of RORgammat in promoting IL-17A expression. J. Biol. Chem. 290, 29086-29094.
DOI
|
97 |
Wu, Q., Nie, J., Gao, Y., Xu, P., Sun, Q., Yang, J., Han, L., Chen, Z., Wang, X., Lv, L., et al. (2015). Reciprocal regulation of RORgammat acetylation and function by p300 and HDAC1. Sci. Rep. 5, 16355.
DOI
|
98 |
Yamagata, T., Mitani, K., Oda, H., Suzuki, T., Honda, H., Asai, T., Maki, K., Nakamoto, T., and Hirai, H. (2000). Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organs. EMBO J. 19, 4676-4687.
DOI
|
99 |
Harris, M.L., Darrah, E., Lam, G.K., Bartlett, S.J., Giles, J.T., Grant, A.V., Gao, P., Scott, W.W., Jr., El-Gabalawy, H., Casciola-Rosen, L., et al. (2008). Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum. 58, 1958-1967.
DOI
|
100 |
Ho, I.C., Hodge, M.R., Rooney, J.W., and Glimcher, L.H. (1996). The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85, 973-983.
DOI
|
101 |
Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061.
DOI
|
102 |
Hosokawa, H., Kato, M., Tohyama, H., Tamaki, Y., Endo, Y., Kimura, M.Y., Tumes, D.J., Motohashi, S., Matsumoto, M., Nakayama, K.I., et al. (2015). Methylation of Gata3 protein at Arg-261 regulates transactivation of the Il5 gene in T helper 2 cells. J. Biol. Chem. 290, 13095-13103.
DOI
|
103 |
Szabo, S.J., Sullivan, B.M., Stemmann, C., Satoskar, A.R., Sleckman, B.P., and Glimcher, L.H. (2002). Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295, 338-342.
DOI
|